Moosacher Straße 88
Munich 80809
Germany
49 89 307602 0
https://www.synlab.com
Settore/i:
Settore:
Impiegati a tempo pieno: 23.538
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Mathieu Floreani | Chairman of the Management Board & CEO | 2,39M | N/D | 1967 |
Dr. Bartholomäus Wimmer | Founder & Independent Member of the Supervisory Board | 132k | N/D | 1962 |
Mr. Sami Badarani | CFO & Member of Management Board | 1,5M | N/D | 1963 |
Mr. Robert Steinwander | Group Chief Operating Officer | N/D | N/D | N/D |
Mr. Henrik Andreasen | Group Chief Information Officer | N/D | N/D | N/D |
Dr. Anna Niedl | Head of Investor Relations | N/D | N/D | N/D |
Ms. Kimberly Urdahl | Group General Counsel & Group Chief Compliance Officer | N/D | N/D | N/D |
Alexander Hagen | Group Head of Commercial & Marketing | N/D | N/D | N/D |
Ms. Catharina Monster | Group Chief Human Resources Officer | N/D | N/D | N/D |
Mr. Luis Vieira | Group Chief Strategy Officer | N/D | N/D | N/D |
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.
L'ISS Governance QualityScore di SYNLAB AG al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.